InMed Pharmaceuticals Stock (NASDAQ: INM) stock price, news, charts, stock research, profile.
Open | $0.270 |
Close | - |
Volume / Avg. | 48.315K / 391.487K |
Day Range | 0.262 - 0.277 |
52 Wk Range | 0.228 - 2.080 |
Market Cap | $1.612M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 5.93% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of InMed Pharmaceuticals (NASDAQ: INM) through any online brokerage.
There are no as such competitors for InMed Pharmaceuticals.
The latest price target for InMed Pharmaceuticals (NASDAQ: INM) was reported by HC Wainwright & Co. on Monday, November 29, 2021. The analyst firm set a price target for 6.00 expecting INM to rise to within 12 months (a possible 2155.64% upside). 0 analyst firms have reported ratings in the last year.
The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $0.266 last updated Today at May 16, 2024 at 9:27 AM EDT.
There are no upcoming dividends for InMed Pharmaceuticals.
InMed Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for InMed Pharmaceuticals.
InMed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.